{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:33:41Z","timestamp":1789353221820,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T00:00:00Z","timestamp":1173225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000267","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T23:06:03Z","timestamp":1173222363000},"page":"e267","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization"],"prefix":"10.1371","volume":"2","author":[{"given":"Jaspreet Singh","family":"Jaggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya V.","family":"Seshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Kappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debjit","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Benezra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.","volume":"86","author":"D Hanahan","year":"1996","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ijrobp.2003.10.057","article-title":"A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.","volume":"58","author":"L Li","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","article-title":"Vascular targeting agents as cancer therapeutics.","volume":"10","author":"PE Thorpe","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/cbr.2000.15.71","article-title":"Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.","volume":"15","author":"SJ DeNardo","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/092986706776361085","article-title":"Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.","volume":"13","author":"H Zhong","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1471-4892(01)00065-0","article-title":"Antiangiogenic and antivascular therapy for cancer.","volume":"1","author":"G Taraboletti","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"ref7","first-page":"1127","article-title":"Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.","volume":"47","author":"BM Tijink","year":"2006","journal-title":"J Nucl Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(02)03794-X","article-title":"Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: theoretical analysis.","volume":"54","author":"G Akabani","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1667\/0033-7587(2002)157[0633:VTRWTA]2.0.CO;2","article-title":"Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.","volume":"157","author":"SJ Kennel","year":"2002","journal-title":"Radiat Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31959","DOI":"10.1074\/jbc.M103024200","article-title":"Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.","volume":"276","author":"Y Maeshima","year":"2001","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases.","volume":"407","author":"P Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature03794","article-title":"Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.","volume":"436","author":"S Sengupta","year":"2005","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.","volume":"7","author":"RK Jain","year":"2001","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI24612","article-title":"Rapid vascular regrowth in tumors after reversal of VEGF inhibition.","volume":"116","author":"MR Mancuso","year":"2006","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.","volume":"64","author":"RT Tong","year":"2004","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2005-01-0010","article-title":"Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.","volume":"105","author":"C May","year":"2005","journal-title":"Blood"},{"key":"ref17","first-page":"2567","article-title":"Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.","volume":"62","author":"F Liao","year":"2002","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2307\/3578139","article-title":"Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus.","volume":"128","author":"MR Raju","year":"1991","journal-title":"Radiat Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.cdd.4401047","article-title":"Ac-225 and her daughters: the many faces of Shiva.","volume":"9","author":"MR McDevitt","year":"2002","journal-title":"Cell Death Differ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1064126","article-title":"Tumor therapy with targeted atomic nanogenerators.","volume":"294","author":"MR McDevitt","year":"2001","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0969-8043(02)00167-7","article-title":"Design and synthesis of 225Ac radioimmunopharmaceuticals.","volume":"57","author":"MR McDevitt","year":"2002","journal-title":"Appl Radiat Isot"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/0008-5472.CAN-04-3096","article-title":"Efforts to control the errant products of a targeted in vivo generator.","volume":"65","author":"JS Jaggi","year":"2005","journal-title":"Cancer Res"},{"key":"ref23","first-page":"5084","article-title":"Targeted actinium-225 in vivo generators for therapy of ovarian cancer.","volume":"63","author":"PE Borchardt","year":"2003","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1681\/ASN.2004110945","article-title":"Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters.","volume":"16","author":"JS Jaggi","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref25","first-page":"1598","article-title":"Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.","volume":"52","author":"ME Gleave","year":"1992","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.","volume":"8","author":"O Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/1541-7786.36.2.1","article-title":"Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.","volume":"2","author":"J Huang","year":"2004","journal-title":"Mol Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrc1946","article-title":"Predicting benefit from anti-angiogenic agents in malignancy.","volume":"6","author":"AM Jubb","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-04-0859","article-title":"Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.","volume":"10","author":"M Miederer","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1127592","article-title":"Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.","volume":"313","author":"Y Shaked","year":"2006","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness.","volume":"156","author":"H Hashizume","year":"2000","journal-title":"Am J Pathol"},{"key":"ref32","first-page":"3298","article-title":"Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.","volume":"62","author":"JA Tuxhorn","year":"2002","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1097-0185(199709)249:1<63::AID-AR8>3.0.CO;2-G","article-title":"Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.","volume":"249","author":"MJ Wilson","year":"1997","journal-title":"Anat Rec"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2214\/ajr.171.4.9762973","article-title":"Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.","volume":"171","author":"H Daldrup","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"ref35","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.","volume":"6","author":"F Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI25705","article-title":"Pericytes limit tumor cell metastasis.","volume":"116","author":"X Xian","year":"2006","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000087840","article-title":"Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients.","volume":"69","author":"Y Yonenaga","year":"2005","journal-title":"Oncology"},{"key":"ref38","first-page":"1843","article-title":"The microtubule-affecting drug paclitaxel has antiangiogenic activity.","volume":"2","author":"D Belotti","year":"1996","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/1078-0432.CCR-05-2762","article-title":"Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus cremophor EL-based paclitaxel.","volume":"12","author":"SS Ng","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T14:02:23Z","timestamp":1707660143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000267"}},"subtitle":[],"editor":[{"given":"Mikhail","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,3,7]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000267","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,7]]}}}